Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on Altimmune (ALT – Research Report) today and set a price target of $18.00. The ...

The benchmark S&P 500 closed down 10% from its February peak. The whirlwind of tariff announcements in recent weeks have ...

Shares in financial firm Stifel (SF) dropped 3% today after it was told to cough up $132.5 million in damages to a U.S.

(Reuters) - Stifel Financial was ordered by a Financial Industry Regulatory Authority arbitration panel to pay a family ...